Corporate governance statement of conformity pursuant to Section 289f and Section 315d of the German Commercial Code (HGB)

The corporate governance statement of conformity of BRAIN Biotech AG pursuant to Section 289f and Section 315d of the German Commercial Code (HGB) is published on the website at:

https://www.brain-biotech-group.com/en/investors/corporate-governance/

Zwingenberg, 13 January 2025

Adriaan Moelker
Chief Executive Officer

Michael Schneiders
Chief Financial Officer